---
category: news
title: "Neoleukin Therapeutics: De Novo Protein Design Platform"
excerpt: "Neoleukin is a leader in de novo drug design. The company's lead asset was recently put on clinical hold, pending more dosing data, creating a window to buy the stock."
publishedDateTime: 2021-02-03T17:16:00Z
originalUrl: "https://seekingalpha.com/article/4403044-neoleukin-therapeutics-de-novo-protein-design-platform"
webUrl: "https://seekingalpha.com/article/4403044-neoleukin-therapeutics-de-novo-protein-design-platform"
type: article
quality: 24
heat: 24
published: false

provider:
  name: Seeking Alpha
  domain: seekingalpha.com

topics:
  - Google AI
  - AI

images:
  - url: "https://static.seekingalpha.com/uploads/2021/2/2/saupload_xKHvUCjiNtdzHZnqgZvCdxEVRlFJlcA-U1bnsI2tlJiTUgKQTfESbMZL0m9oyRjVVZm1Q_r3z2ayp0ZCuku-Z2JtKXsdrlmyDoVOgpwh4Qy4EeTpUhD9p6zDfeDDi4e8yL2nu2x6.png"
    width: 1016
    height: 505
    isCached: true

secured: "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;Q99upU1v6h4iDpH/rQjq3w=="
---

